Healthier Capital
VC Fund
Healthier Capital is a VC fund focused on Health Care and Medical. Healthier Capital aims to significantly increase healthcare impact and value development by collaborating with exceptional innovators.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 71%
Last updated:
For AI agents: llms.txt
Industries Healthier Capital invests in
Stages Healthier Capital invests in
Countries Healthier Capital invests in
Investment Focus
Industry
- Health Care 6 (43%)
- Medical 3 (21%)
- Artificial Intelligence 3 (21%)
- B2B 1 (7%)
- SaaS 1 (7%)
Stage
- Series A 4 (29%)
- Series B 4 (29%)
- Funding Round 2 (14%)
- Seed 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Dandelion Health AI
|
Dandelion Health AI develops a clinical data and artificial intelligence platform that enables life sciences companies and researchers to analyze real-world patient data and accelerate drug development and clinical research. The company provides a precision medicine platform that aggregates multimodal healthcare data, including clinical notes,medical images, and physiological waveforms, into a unified dataset representing patient journeys over time. Its platform applies validated AI models to transform large volumes of unstructured clinical data into structured, research-ready datasets, allowing researchers to uncover insights into disease progression, treatment effectiveness, and patient outcomes. This capability enables more comprehensive analysis compared to traditional datasets that rely primarily on structured records such as claims or diagnostic codes. | $14M / Series A / May 05, 2026 | |
Photon
|
A modern prescription network | $16M / Series A / Apr 30, 2026 | |
Qualified Health
|
Qualified Health is a reliable partner for safely utilizing generative AI in medicine. Qualified Health's infrastructure solution offers safeguards for ongoing algorithm performance monitoring, active AI governance, and developing agents tailored to the healthcare industry. Qualified Health are revolutionizing healthcare in America with tophealth system partners. | $125M / Series B / Mar 25, 2026 | |
|
Diploid Genomics
|
Diploid Genomics is creating a next-generation discovery and diagnostics platform for complicated and lethal diseases that will make future health outcomes more predictable, measurable, and actionable. | Seed / Jan 23, 2026 | |
Zarminali Health
|
Zarminali Health transforms pediatric care by building multispecialty pediatric group that provides modern, seamlessly coordinated care. | $110M / Series A / Jan 21, 2026 | |
Amae Health
|
Amae Health provides outpatient care that integrates psychiatric treatment, primary care, therapy, and peer support for adults living with severe mental illness. The company delivers personalized treatment plans through multidisciplinary teams comprising psychiatrists, therapists, primary care physicians, health coaches, dietitians, and peermentors. Its services cover conditions such as schizophrenia, bipolar disorder, refractory depression, trauma, and co-occurring substance-use disorders, and it emphasizes long-term engagement and whole-person wellness. Amae Health also collaborates with academic medical centers to develop clinician training programs and to use data-driven insights to refine care pathways. | $25M / Series B / Nov 06, 2025 | |
Hyro
|
Hyro creates plug-and-play conversational AI assistants by seamlessly ingesting data on digital channels to allow users to interact with information via voice or chat simply and intuitively, allowing for increased engagement and conversions. Unlike existing solutions, Hyro provides organisations with frictionless deployment and maintenanceprocesses by automatically building a knowledge graph out of their existing content without any integration, playbooks, or training data. | $45M / Oct 21, 2025 | |
Daymark Health
|
Daymark Health is a cancer care company that focuses on providing in-home and virtual supportive care to cancer patients in collaboration with health plans. The company offers a wide range of supportive care services, including behavioral health care and social support, aimed at meeting the comprehensive needs of cancer patients. Daymark Healthconnects primary care physicians, oncologists, and other care teams to create a seamless and supportive experience for patients, leveraging both virtual and home-based care methodologies. | $20M / Series A / Sep 25, 2025 | |
|
Qualified Health
|
Qualified Health is a reliable partner for safely utilizing generative AI in medicine. Qualified Health's infrastructure solution offers safeguards for ongoing algorithm performance monitoring, active AI governance, and developing agents tailored to the healthcare industry. Qualified Health are revolutionizing healthcare in America with tophealth system partners. | $30M / Seed / Jan 08, 2025 | |
|
Hyro
|
Hyro creates plug-and-play conversational AI assistants by seamlessly ingesting data on digital channels to allow users to interact with information via voice or chat simply and intuitively, allowing for increased engagement and conversions. Unlike existing solutions, Hyro provides organisations with frictionless deployment and maintenanceprocesses by automatically building a knowledge graph out of their existing content without any integration, playbooks, or training data. | $15M / Series B / Dec 10, 2024 | |
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Healthier Capital invest in?
Healthier Capital invests primarily in Health Care, Medical and Artificial Intelligence startups, most often at Series A and Series B stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Healthier Capital last invest?
The most recent investment recorded for Healthier Capital closed in May 2026. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
